DOST doubling efforts to fight CoVID-19; VCO clinical trials for CoVID patients ongoing
2020-04-30
27
DOST doubling efforts to fight CoVID-19; VCO clinical trials for CoVID patients ongoing
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
Clinical trials ng DOST para sa mga posibleng gamot vs. COVID-19, patuloy; clinical trial para sa VCO bilang lunas vs. COVID-19, target matapos sa susunod na buwan
VCO, posibleng maging gamot laban sa COVID-19; COVID-19 patients na uminom ng VCO, mas mabilis na gumaling; Lagundi at Tawa-tawa, pinag-aaralan ng DOST bilang alternatibong gamot vs. COVID-19
VCO, nakatutulong para mabawasan ang sintomas ng mga probable at suspected COVID-19 cases ayon sa DOST, pero ang DOH sinabing hindi gamot ang VCO para sa COVID-19
DOST study on VCO yields promising results on mild case of COVID-19; DOST conducting study on use of lagundi against COVID-19 | via @louisaerispePTV
8Resulta ng Clinical Trial sa VCO vs. COVID-19, ilalabas na sa katapusan ng Setyembre; Lagundi, nakatutulong maibsan ang sintomas ng COVID-19 ayon sa DOST
DOH, PNAC doubling efforts as HIV/AIDS cases in PH increase
VCO showing promising effect on mild CoVID-19 cases; Lagundi to undergo clinical trials as CoVID-19 supplement treatment
Camiguin LGU doubling efforts to attract more tourists
DOST preparing for trials on mixing and matching COVID-19 vaccines; DOST: 4 COVID-19 vaccines approved by FDA; OCTA: NCR should remain under GCQ classification despite improving stats
Bisa ng VCO, lagundi at tawa-tawa vs. COVID-19, patuloy na pinag-aaralan ng DOST
